47335-625 : Aspruzyo Sprinkle 1000 mg Oral Granule


NDC47335-625
Labeler: Sun Pharmaceutical Industries, Inc.
Product Type: Human Prescription Drug
Drug Name:  Aspruzyo Sprinkle
Dosage Form: Oral Granule
Application #: NDA216018
Rev. Date: 


NDC Package Codes:

  • 47335-625-11: 1 GRANULE IN 1 PACKET (47335‑625‑11)
  • 47335-625-30: 30 GRANULE IN 1 CARTON (47335‑625‑30)
  • 47335-625-60: 60 GRANULE IN 1 CARTON (47335‑625‑60)

Active Ingredients:

  • Ranolazine

Dosage Strength:

  • 1000 mg

Pharmaceutical Classes:

  • Anti-anginal [EPC]
  • Cytochrome P450 2D6 Inhibitors [MoA]
  • Cytochrome P450 3A Inhibitors [MoA]
  • Organic Cation Transporter 2 Inhibitors [MoA]
  • P-Glycoprotein Inhibitors [MoA]

Related Products:

Based on records with the same trade name.
  • 47335-624 Aspruzyo Sprinkle 500 mg Oral Granule by Sun Pharmaceutical Industries, Inc.

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 47335-625 QR Code

< Prev: 47335-624Next: 47335-631 >

Related Discussions:

Ranolazine 500mg
My mother is 65 years old, consuming Ranolazine - but i dont know what for? Please advise me. ## Ranolazine, the active ... 3 replies
can Nikoran be used with ranolazine
In refractory angina after angioplasty what should be treatment guidelines ## I'm using nicorandil 10mg twice daily ... 1 reply
Depakote pill form or sprinkle medication not helping
Why is a medication my doctor gave me to "lower my peak (i can't remember the medical term), causing me more anx... 1 reply
Ranolazine for SOB
I am 82 now. When I walk some distance I get heavy breathing. Indoors I am perfectly ok. CT angiogram and ECG normal. No...




Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.